Cspc Zhongnuo Pharmaceutical (shijiazhuang) Co., Ltd.

This study compares a new version of the long-acting schizophrenia injection paliperidone palmitate (given every 3 months) to the approved drug Invega Trinza. About 260 adults with stable schizophrenia will receive multiple doses to see if the new formulation works similarly in t…

This study tests a new medicine called SYH2053, given as a shot under the skin, to see if it safely lowers 'bad' LDL cholesterol in people with high cholesterol or mixed lipid problems. About 760 adults whose cholesterol is not at goal will receive either the drug or a placebo. T…

This early-stage study tests whether a new injection called SYH2070 is safe and how the body processes it. About 48 healthy adults aged 18-60 will receive either the drug or a placebo. The goal is to check for side effects and measure drug levels in the blood, not to treat any di…